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The maturation of immature B cells and the survival of mature B cells is stringently
controlled to maintain a diverse repertoire of antibody specificities while avoiding self-
reactivity. At the molecular level this is regulated by signaling from membrane Ig and
the BAFF-receptor that sustain a pro-survival program of gene expression. Whether and
how posttranscriptionalmechanisms contribute to B cell maturation and survival remains
poorly understood. Here, we show that the polypyrimidine tract binding proteins (PTBP)
PTBP1 and PTBP3 bind to a large and overlapping set of transcripts in B cells. Both PTBP1
and PTBP3 bind to introns and exons where they are predicted to regulate alternative
splicing. Moreover, they also show high-density of binding to 3’ untranslated regions sug-
gesting they influence the transcriptome in diverse ways.We show that PTBP1 and PTBP3
are required in B cells beyond the immature cell stage to sustain transitional B cells and
the B1, marginal zone and follicular B cell lineages. Therefore, PTBP1 and PTBP3 promote
the maturation of quiescent B cells by regulating gene expression at the posttranscrip-
tional level.
Keywords: mature B cells  posttranscriptional gene expression regulation  PTBP1  PTBP3 
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 Additional supporting information may be found online in the Supporting Information sectionat the end of the article.
Introduction
The maturation of naïve B cells occurs through discrete stages.
In the bone marrow, developing B cells express IgM at their cell
surface and are defined as immature. These B cells migrate to the
spleen where they mature through different transitional stages
(T1 and T2) [1, 2], express BAFF-receptor and establish a home-
ostatic survival-circuit dependent upon its ligand [3, 4]. Mature
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naïve B cells express IgD in addition to IgM and may recirculate
between lymphoid follicles or reside in the marginal zones of the
spleen. The maturation and survival of mature B cells is depen-
dent upon signaling by surface Ig, and gene regulation by DNA
binding transcription factors [4]. The contribution of posttran-
scriptional regulation of mRNA processing, stability, or translation
is less well characterized [5, 6].
RNA binding proteins (RBP) acting posttranscriptionally deter-
mine the quantity and variants of transcripts produced from
genes. They also regulate where, and in what amounts, mRNAs
are translated. The role of these regulatory processes in B cell
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development is a new and exciting area. Polypyrimidine tract
binding protein (PTBP) 1 is a widely expressed alternative splic-
ing regulator. It has additional, less well-characterized, roles in
regulating microRNA processing, mRNA abundance, alternative
polyadenylation, and internal ribosome entry site-mediated trans-
lation [7]. Studies of B cells with Cd79a(Mb1)Cre-mediated con-
ditional deletion of Ptbp1 showed it was dispensable for B cell
development, but important for the generation of GC B cells and
antigen-specific antibodies [8, 9]. Absence of PTBP1 in B cells led
to the expression of PTBP2 [8], which is expressed in the brain
[7]. In mice with Cd79aCre-mediated conditional deletion of both
Ptbp1 and Ptbp2, B cell development is blocked at the pro-B cell
stage [10]. This is associated with defective cell cycle regulation
in pro-B cells and shows that PTBP2, which is silenced by PTBP1,
compensates for the lack of PTBP1.
The paralog PTBP3 is expressed specifically in cells of the
hematopoietic system. In B cells, PTBP1 and PTBP3 are found
in the nucleus whereas PTBP3 is also detected in the cytoplasm
[11]. The prominent cytoplasmic localization of PTBP3 suggests
that in addition to nuclear roles it may also affect mRNA stability,
translation, or localization. Knowledge of PTBP3 in physiologi-
cal systems is limited with a report that Ptbp3–/– mice have nor-
mal B cell development, but defective antibody responses [12].
However, when Ptbp3 was deleted conditionally in B cells with
the Cd79aCre allele we found normal B cell development, anti-
body amounts, and affinity maturation in response to immuniza-
tion ([10] and unpublished data). Here, we show that PTBP1 and
PTBP3 act redundantly to promote the maturation and mainte-
nance of B cells.
Results and discussion
PTBP1 and PTBP3 bind redundantly to introns and
3’-UTRs
Since both PTBP1 and PTBP3 are highly homologous, particularly
within their RNA binding domains, we compared their transcript-
binding profile by direct mapping binding sites in the B cell tran-
scriptome using individual-nucleotide resolution UV cross-linking
and immunoprecipitation (iCLIP) [13]. We used LPS-activated
splenic B cells. A comparison of the genes expressed with at least
one FPKM in LPS-activated B cells to ex vivo-isolated splenic B cells
revealed a 91% overlap (Supporting Information Fig. S1A). These
iCLIPs revealed the same polypyrimidine-tract binding motifs for
PTBP1 and PTBP3 (Fig. 1A). In addition to the expected bind-
ing to introns, we found prominent binding of both proteins to 3’
untranslated regions (3’-UTRs) (Fig. 1B). We found a higher den-
sity of PTBP3 binding to 3’-UTRs compared to PTBP1 (Fig. 1C).
Conversely, there was a higher density of PTBP1 binding to introns
compared to PTBP3 (Fig. 1C), which is consistent with the pre-
dominant nuclear localisation of PTBP1 [11].
Detailed analysis of individual binding sites, such as those
in transcripts encoding IgM and IgD heavy chains (Ighm and
Ighd) and the BAFF-receptor (Tnfrsf13c), showed that PTBP1 and
PTBP3 bound largely to the same sites (Fig. 1D). We observed
binding of both PTBPs to the IgM M2 exon where PTBP1 has been
shown to suppress an enhancer of splicing that promoted exon
inclusion [14]. To define reproducible binding sites, we chose
a cut-off of at least three independent cDNA reads in the iCLIP
(and FDR<0.05). With these settings, we found that PTBP1 and
PTBP3 bound to transcripts of 9,035 genes with a large overlap
of 64% (5,803 genes) (Fig. 1E, Supporting Information Table S1).
This is an underestimate of genes bound by both PTBPs, since
there will be genes bound by both PTBPs for which one PTBP did
not pass our cut-off criteria. PTBP3 bound to the 5’-UTR and 3’-
UTR of more genes than PTBP1 (Fig. 1E), reflecting the greater
cytoplasmic localization of PTBP3 compared to PTBP1. Amongst
the 12,657 polyadenylated genes detected in LPS-activated B cells
with at least one FPKM, PTBP1 and PTBP3 bound to 7,644 (60%)
(Supporting Information Fig. S1B), highlighting their potential to
regulate numerous genes and pathways. Altogether, although we
found some small differences, these RBPs showed a highly redun-
dant pattern of binding consistent with them regulating the same
RNAs in B cells.
PTBP1 and PTBP3 are necessary for B cell maturation
We found previously that Cd79aCre-mediated deletion of
Ptbp1 and Ptbp3 together did not affect the numbers
of pre- and immature-B cells in the bone marrow in
Cd79aCre/+Ptbp1fl/flPtbp3fl/fl (P1P3 CD79a dKO) mice [10]. In con-
trast, in the spleen, we observed a reduction in the frequency
of B220+CD19+ cells (Fig. 2A). Among CD93+ B cells in P1P3
CD79a dKO mice, there was an increase in the proportions of
the first transitional T1 cells compared to littermate control mice
(Fig. 2A). The enumeration of cells showed an almost complete
absence of mature B cells in P1P3 CD79a dKO mice (Fig. 2B).
The numbers of cells in the T2 and T3 subsets were reduced
by 9.7- and 17-fold, respectively, with the T1 subset the least
affected being reduced by 3.5-fold. In the peritoneal lavage, there
were few B cells and CD19highB220low B1 B cells were clearly
depleted (Supporting Information Fig. S2A). Intracellular stain-
ing for PTBP1 and PTBP3 in B cells from P1P3 CD79a dKO mice
showed efficient protein depletion but, unlike control cells, they
express PTBP2 (Fig. 2C; Supporting Information Fig. S2B).
We found that P1P3 CD79a dKO mice became severely unwell
and had to be culled between 10–12 weeks of age. At necropsy, it
was apparent that the kidneys were abnormal with signs of poly-
cystic lesions (Supporting Information Fig. S2C). There have been
reports of Cd79aCre expression in the kidney [15] and conditional
KO of Tsc1 with Cd79aCre led to a polycystic kidney phenotype
[16], suggesting that Ptbp1 and Ptbp3 deletion with the Cd79aCre
led to these lesions, but this will have to be confirmed. To establish
if the B cell phenotype was intrinsic to the hematopoietic system
we transferred bone marrow from Cd79aCre/+Ptbp1+/+Ptbp3+/+
control or P1P3 CD79a dKO mice into lethally irradiated B6.SJL
mice. There was no early-onset disease or kidney abnormalities
found in these chimeras. Following reconstitution, as with intact
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Figure 1. PTBP1 and PTBP3 bind redundantly to the transcriptome of B cells. (A) Z-score correlation of motifs found in PTBP1 and PTBP3 iCLIPs.
(B) Proportions of xlink-binding sites in different genomic features in PTBP1 and PTBP3 iCLIPs. (C) Density enrichment of xlink-binding sites in
different genomic features in PTBP1 and PTBP3 iCLIPs. (D) Significant (FDR<0.05) xlink-binding sites and number of cDNAs identified on each site
along Ighm, Ighd, and Tnfrsf13c transcripts in PTBP1 and PTBP3 iCLIPs. (E) Overlaps of number of genes with a xlink-binding site (FDR < 0.05) with a
height ≥3 meaning that the xlink-binding site was identified with ≥3 independent cDNAs in PTBP1 and PTBP3 iCLIPs.
mice, the numbers of all splenic transitional and mature B cell sub-
sets in P1P3 CD79a dKO were substantially reduced compared to
control chimeras (Fig. 2D; Supporting Information Fig. S2D). The
proportions of B cells and the ratio of B cells compared to T cells
in the blood were reduced 2.4- and 5.7-fold, respectively, in P1P3
CD79a dKO compared to control chimeras (Supporting Informa-
tion Fig. S2E and S2F). Histological examination of the spleens
from P1P3 CD79a dKO chimeras showed the few B cells present
localized around the T cell zone indicating unaffected migration
of the PTBP1 and PTBP3-deficient B cells in the spleen (Fig. 2E).
A defect in the export of PTBP1 and PTBP3 deficient immature B
cells could contribute to the reduced number of T1 B cells. These
data revealed the indispensable role of PTBP1 and PTBP3 in the
differentiation or maintenance of mature B cells in the spleen
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Figure 2. PTBP1 and PTBP3 are necessary for B cell maturation and maintenance. (A) Flow cytometry gating strategy identifying B cell populations
amongst splenocytes.Numbers shown are percentages. (B) Numbers of cells in spleens identified as shown in (A). Bars show arithmeticmeans. Each
symbol shows data from one mouse. P-values from two-tailed unpaired Student’s t-test are shown. Data from five- to six-mice pooled from two
independent experiments are shown. (C) Intracellular PTBP1 and PTBP3 staining analysed by flow cytometry in splenic B cells. Full gating strategy is
shown in Supporting Information Fig. S2B. Data shown are from one mouse of each genotype from one experiment with three mice per genotype.
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and the peritoneum—a role that cannot be compensated for
by PTBP2.
PTBP1 and PTBP3 are necessary for the maintenance
of mature B cells
To study the mature B cell compartment further we used Cd23CreTg
[17], which mediates recombination in transitional B cells to gen-
erate Cd23CreTgPtbp1fl/flPtbp3fl/fl mice (P1P3 CD23 dKO) and ana-
lyzed splenic B cell subsets by flow cytometry (Fig. 2F). The num-
bers of T1, T2, and T3 B cells in P1P3 CD23 dKO mice were similar
to those in Cd23CreTgPtbp1+/+Ptbp3+/+ or Ptbp1fl/flPtbp3fl/fl mice
(Fig. 2G). By contrast, the numbers of B cells with the follicular
or marginal zone (MZ) phenotype in the spleen were substan-
tially reduced (Fig. 2G). Identification of MZ B cells with staining
of CD21 and CD23 also showed a reduction in MZ B cell num-
bers in the spleen and revealed lower staining of CD21 in PTBP1
and PTBP3-deficient cells compared to control B cells (Supporting
Information Fig. S3A). In addition, the numbers of B cells from
lymph nodes were reduced by three-fold in P1P3 CD23 dKO mice
(Fig. 2H, Supporting Information Fig. S3B).
The presence of both PTBP1 and PTBP3 proteins in T1 and
T2 cells from P1P3 CD23 dKO mice (Supporting Information Fig.
S3C) was consistent with the minimal impact on cell numbers
at these stages. Follicular B cells in both the spleen and lymph
node showed a large proportion of cells that retained expression
of PTBP1 and PTBP3 (Supporting Information Fig. S3C and S3D)
at the levels of control and Ptbp1 and Ptbp3 heterozygous CD23
KO mice (Supporting Information Fig. S3E). Yet their absolute
numbers were reduced two to three-fold in the P1P3 CD23 dKO
mice (Fig. 2G and H). Moreover, cells with maintained PTBP1 and
PTBP3 expression were abundant amongst MZ B cells (Supporting
Information Fig. S3C).
We assessed IgM and IgD surface levels in PTBP1 and PTBP3-
deficient mature B cells from P1P3 CD23 dKO mice where we
could assess consequences of recent PTBP1 and PTBP3 protein
depletion in B cells. IgM and IgD staining in PTBP1 and PTBP3-
deficient mature B cells were unaffected (Supporting Informa-
tion Fig. S3F). Also, BTK and AKT phosphorylation at Tyrosine
223 and Threonine 308, respectively, upon IgM crosslinking was
unaffected in PTBP1 and PTBP3-deficient mature B cells (data
not shown). PTBP1 and PTBP3-deficient mature B cells expressed
PTBP2 (Supporting Information Fig. S3C) suggesting that PTBP2
compensated for some roles of PTBP1 and PTBP3. Nonetheless,
PTBP2 in follicular and MZ B cells was unable to support these
cells revealing a role for PTBP1 and PTBP3 in the maintenance of
mature B cell subsets.
Reduced BAFF-receptor in the absence of PTBP1 and
PTBP3
BAFF signaling is critical for the maturation and maintenance of
B cells [3, 4] and BAFF-receptor is induced by tonic signaling
[18]. PTBP1 and PTBP3 bound to the 3’UTR of Tnfrsf13c (encod-
ing BAFF-receptor) (Fig. 1D). BAFF-receptor staining was reduced
in PTBP1 and PTBP3 deficient B cells from the P1P3 CD79a dKO
chimeras and the P1P3 CD23 dKO mice (Fig. 3A–D). This reduc-
tion could be a direct effect of PTBP1 and PTBP3 in control-
ling Tnfrsf13c mRNA abundance or translation or also a result of
impaired tonic signaling. We cultured B cells isolated from lymph
nodes of P1P3 CD23 dKO mice and control littermate mice ex
vivo with or without exogenous BAFF (Fig. 3E). The numbers of B
cells from P1P3 CD23 dKO mice we recovered after several days
in culture were unaffected even though B cells from P1P3 CD23
dKO in culture had lost PTBP1 and PTBP3 proteins (Fig. 3F). This
showed that PTBP1 and PTBP3-deficient mature B cells respond
to exogenous BAFF which promotes their survival ex vivo. Thus,
we expect that in vivo PTBP1 and PTBP3 are necessary for con-
trolling expression at the posttranscriptional level of many other
genes necessary for B cell maturation and maintenance in addi-
tion to BAFF-receptor and the absence of B1 cells in P1P3 CD79
dKO mice reflects this.
Concluding remarks
The requirement of both PTBP1 and PTBP3 in transitional and
mature B cells contrasts with early B cell development where
PTBP2 compensated completely for the absence of these proteins
[10]. In mouse brain, PTBP1 and PTBP2 bind redundantly largely
to the same sites [19]. Therefore, we expect PTBP2 to bind to
the same sites as PTBP1 and PTBP3 do in B cells. The inability
of PTBP2 to sustain B cell maturation may reflect qualitative dif-
ferences between the paralogs, as PTBP2 is not thought to enter

(D) Numbers of cells in spleens from B6.SJL mice irradiated and reconstituted with bone marrow cells from control (Cd79aCre/+Ptbp1+/+Ptbp3+/+)
or P1P3 CD79a dKO mice. Flow cytometry gating strategy is shown in Supporting Information Fig. S2D. Each symbol shows data from one mouse.
P-values shown are from a two-tailed unpaired Student’s t-test. Bars show arithmetic means. Data are from one experiment with four mice per
group. (E) Immunofluorescence of spleen sections from B6.SJL mice reconstituted with bone marrow cells from control (Cd79aCre/+Ptbp1+/+Ptbp3+/+)
or P1P3 CD79a dKOmice. B cells were identifiedwith anti-IgM shown inmagenta and anti-IgD shown in yellow. T cells were identified with anti-CD3
shown in blue. Images were captured at 20× magnification. Each image is from a different mouse. Data are from one experiment with four mice.
(F) Flow cytometry gating strategy to identify B cell populations among splenocytes. Events shown in first pseudocolor plots have been pre-gated
on live (eFluor780-) single-cell lymphocytes. (G) Numbers of cells in spleens identified as shown in F. Bars show arithmetic means. Each symbol
shows data from one mouse. P-values from two-tailed unpaired Student’s t-test are shown. Data shown are representative from one out of two
independent experiments with two to six mice per genotype in each experiment. (H) Numbers of follicular B cells found in peripheral (axillar,
inguinal, and brachial) lymph nodes. Each symbol shows data from one mouse. P-values from two-tailed unpaired Student’s t-test are shown. Data
shown are from one representative out of two independent experiments with two to six mice per genotype per experiment. Gating strategy is
shown in Supporting Information Fig. S3B.
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Figure 3. Reduced BAFF-receptor in the absence of PTBP1 and PTBP3. (A) BAFF-receptor (BAFFR) staining in splenic B cells from B6.SJL chimericmice
and measured by flow cytometry. B cell populations were identified as shown in Supporting information Fig. S2D. (B) Geometric mean fluorescence
intensity (gMFI) of the staining shown in A. (C) BAFFR staining of follicular B cells from the spleen and lymph nodes andmeasured by flow cytometry.
B cells were pre-gated on the levels of PTBP1 as shown in Supporting Information Fig. S3F. (D) gMFI of the staining shown in C. (E) Live B cells isolated
from lymph nodes recovered after several days of culture with or without exogenous BAFF (200 ng/ml). Live cells (eFluor780-) were analyzed by flow
cytometry. (F) Intracellular staining of live B cells (eFluor780-, B220+) cultured for one day without BAFF as shown in E. Intracellular staining of B
cells cultured with BAFF was similar to that without BAFF. In (B, D, and E), each point shows data from one mouse. Bars show arithmetic means. In
(B and E) P-adjusted values from two-tailed Student’s t-test corrected by two-stage step-up method of Benjamini, Krieger, and Yekutieli are shown.
(D) P-values from unpaired two-tailed Student’s t-test are shown. In (B and D), data shown are from one experiment with four to six mice per
genotype. (E) Data shown are from one of two independent experiments with three to four mice per genotype in each experiment.
the cytoplasm. However, it is also possible that all three paralogs
have redundant roles and that PTBP2 abundance is insufficient to
ensure B cell maturation and maintenance.
Given their widespread binding, we expect that PTBP1 and
PTBP3 will control many genes necessary for the maintenance of
mature B cell populations. In addition to Tnfrsf13c binding, PTBP1
and PTBP3 bound to exons, introns, and 3’UTRs Bcl2, Syk, Akt1,
Cxcr4, and S1pr1 among many other genes (Supporting Informa-
tion Table S1 and Fig. S1B). Further investigations are warranted
to elucidate if and how PTBP1 and PTBP3 control expression of
these targets necessary for the export of immature B cells from the
bone marrow and survival, tonic signaling, and maintenance of
mature B cells. We anticipate diverse and shared roles for PTBP1
and PTBP3 in B cells including the control of alternative splicing
and also other functions via 3’-UTR-binding such as mRNA local-
ization, stability, and translation.
Materials and methods
Mice and bone marrow chimeras
Mice were maintained in the Babraham Institute Biological
Support Unit. No primary pathogens or additional agents listed
in the FELASA recommendations have been confirmed dur-
ing health monitoring since 2009. Ambient temperature was
∼19–21°C and relative humidity 52%. Lighting was provided
on a 12hr light: 12hr dark cycle including 15 min ‘dawn’ and
‘dusk’ periods of subdued lighting. After weaning, mice were
transferred to individually ventilated cages with one to five mice
per cage. Mice were fed CRM (P) VP diet (Special Diet Services)
ad libitum and received seeds (e.g., sunflower, millet) at the time
of cage-cleaning as part of their environmental enrichment. All
mouse experimentation was approved by the Babraham Institute
Animal Welfare and Ethical Review Body. Animal husbandry and
experimentation complied with existing European Union and
United Kingdom Home Office legislation. All mice were used
experimentally between 8- and 25-weeks of age (for bone marrow
chimeras) and were age- and sex-matched within experiments. No
sex-associated differences were observed in the results obtained.
Mice were on the C57BL/6 background and derived from cross-
ing the following transgenic strains: Ptbp1fl/fl (Ptbp1tm1Msol)
[20], Ptbp3fl/fl (Ptbp3tm1Tnr) [10], Cd79aCre (Cd79atm1(cre)Reth)
[15], and Cd23CreTg (Cd23-creTg(Fcer2a-cre)5Mbu) [17]. To generate
chimeras, B6.SJL mice were lethally irradiated (2 × 0.5 Gy)
and reconstituted with 3 × 106 bone marrow cells derived
from control (Cd79aCre/+Ptbp1+/+Ptbp3+/+) or P1P3 CD79a dKO
mice.
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Flow cytometry
Cell surface and intracellular staining for flow cytometry analy-
ses were carried out as described [10] adhering to the guide-
lines for the use of flow cytometry [21]. The antibodies used
were: B220-FITC (RA3-6B2, Tonbo, cat#:35-0452), B220-PECy7
(RA3-6B2, eBioscience, cat#:25-0452-82), B220-BUV395 (RA3-
6B2, BD, cat#:563793), CD19-PerCPCy5.5 (1D3, Biolegend,
cat#:152406), CD19-BUV395 (1D3, BD, cat#:565965), CD19-
BUV737 (1D3, BD, cat#:564296), CD19-BV421 (6D5, Biole-
gend, cat#:115549), CD93-APC (AA4.1, eBioscience, cat#:17-
5892-83), CD93-BV421 (AA4.1, BD, cat#: 747716), CD23-
BV421 (B3B4, Biolegend, cat#:101621), CD23-PE (B3B4, BD,
cat#: 553139), IgM-BV786 (R6-60.2, BD, cat#: 564028), IgM-
PECy7 (II/41, eBioscience, cat#: 25-5790-81), IgD-PE (11-
26, SouthernBiotech, cat#:1120-09L), IgD-BV510 (11-26c.2a,
Biolegend, cat#:405723), IgD-PerCPCy55 (11-26c.2a, Biole-
gend cat#:405710), TCRb-BUV737 (H57-597, BD cat#:564799),
CD45.2-BV785 (104, Biolegend, cat#:109839), BAFFR-FITC
(eBio7H22.E16, eBioscience, cat# 11-5943-82). Anti-PTBP1
(CLONE 1, ThermoFisher, cat#:32-4800), anti-PTBP2 (S43,
from Michele Solimena), and anti-PTBP3 (MAC454, [8]) anti-
bodies were conjugated to different fluorophores with anti-
body labeling kits from ThermoFisher (AF488, cat#:A20181;
AF647, cat#:A20186 and AF594, cat#:A20185). eFluor780
(ThermoFisher, cat#: 65-0865-18) cell surface staining was used
to identify live cells. Data were analyzed with Flowjo (v 10.7.1).
Statistical analyses were carried out with Prism 8 (v 8.4.3).
B cell isolation and ex vivo culture
B cells were isolated from the lymph nodes using the mouse B cell
isolation kit (Miltenyi, cat#130-090-862). 105 B cells were cul-
tured per well in 96 flat-bottom well plates in RPMI 1640 Medium
(Dutch modification, ThermoFisher, cat#:22409-015) supple-
mented with Glutamax, 10% FCS, 50 μM β-mercaptoethanol,
and 100 units/ml Penicillin and Streptomycin for several days in
the presence or absence of 200 ng/ml exogenous human BAFF
(PeproTech, cat#: 310–13).
Immunofluorescence
Spleens from chimeras were embedded in optimal temperature
cutting medium (OCT) and 10 μm sections cut using a Leica cryo-
stat. Sections were fixed in acetone at −20°C, blocked with 2%
BSA and 10% goat serum, and permeabilized in 2% Triton-X. Sec-
tions were stained with rat anti-mouse IgD-AF647 (11–26c.2a,
BioLegend, cat#:405708); rat anti-mouse IgM-BV421 (R6-60.2,
BD, cat#:562595); and unconjugated hamster anti-mouse CD3
(500A2, eBioscience, cat#:14-0033-85) followed by goat anti-
hamster IgG-AF568 (ThermoFisher, cat#:A-21112). Confocal
images were acquired with a Nikon A1-R confocal microscope
using the 20x/0.8 air objective lens. Laser excitation/emission
detection bands for the three different fluorescent dyes were as
follows (all in nm): BV421, ex408 em450/50; Alexa Fluor 568,
ex562 em595/50, and Alexa Fluor 647, ex640 em700/75. The
system was controlled using Nikon Elements software, with each
fluorescence channel acquired independently to minimize spectral
bleed through. ImageJ software was used to process the images.
iCLIP
The PTBP3 iCLIP reported in this study was carried out with B
cells isolated from the spleen stimulated ex vivo for 48h with
LPS (10 μg/ml, 127:B0, Sigma) as described in [8]. We used
10 μg of the anti-PTBP3 rabbit polyclonal antibody PTBP3-L2-3
[11] and 100 μl protein A magnetic Dynabeads (ThermoFisher,
cat#:10002D). Details of the barcodes and oligos used can be
accessed in GEO under: GSE168769. iCLIP libraries were mapped
to the GRCm38 mouse genome M16 release version from Gen-
code with STAR [22]. cDNA reads were de-duplicated using ran-
dom barcodes included in the library preparation and signifi-
cant (FDR<0.05) xlink-binding sites were identified with iCount
(https://icount.readthedocs.io/en/latest/cite.html). PTBP1 iCLIP
was published previously [8, 10]. FPKMs of ex vivo isolated and
LPS-activated splenic B cells were calculated from mRNAseq data
published under the GSE62129 accession number [23].
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